Clinical Trial Update: A Study of the Perioperative Use of Cetuximab in Colon Cancer Patients [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating perioperative cetuximab in colon cancer patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• Cetuximab (Erbitux) (Cetuximab)

Snippet

Sponsor: St. Luke's-Roosevelt Hospital Center | Conditions: Colon Cancer | Phase 1 | Status: TERMINATED